高级别生物安全实验室实验活动评审中“高致病性病原微生物菌(毒)种和样本管理”专家共识  

Expert consensus on the administration of highly pathogenic microorganisms(virus)and specimen in evaluating the experimental activity of high-grade biosafety laboratory

作　　者：李劲松 张明霞[2] 翁景清 陆兵 张青雯[5] 李娜 LI Jinsong;ZHANG Mingxia;WENG Jingqing;LU Bing;ZHANG Qingwen;LI Na

机构地区：[1]中国医药生物技术协会生物安全专业委员会,北京100022 [2]深圳市第三人民医院,518112 [3]浙江省医学科技教育发展中心,杭州310006 [4]军事科学院军事医学研究院,北京100083 [5]青海省地方病预防控制所,西宁810021

出　　处：《中国医药生物技术》2025年第1期2-12,共11页Chinese Medicinal Biotechnology

摘　　要：在高级别生物安全实验室实验活动评审中,存在着诸多反复出现的共性问题,如“高致病性病原微生物菌(毒)种和样本管理”的共性问题。在国家卫生健康委员会科教司的支持下,中国医药生物技术协会生物安全专业委员会在北京组织召开了高致病性病原微生物菌(毒)种和样本管理共性问题的专家研讨会,就该共性问题中的“双人双锁”和“全生命周期信息管理”两个问题进行了充分研讨,专家对在科技创新发展时代的“锁”的形式和技术可行性、“全生命周期信息管理”的具体内容和可行性进行了研究和讨论,并就具体的技术措施和管理模式形成了专家共识。When evaluating the operational activities of high-grade biosafety laboratories,common issues often arise regarding the management of highly pathogenic microorganisms(viruses)and specimens.With the support of the National Health Committee,the Biosafety Professional Committee of the China Medical Biotechnology Association organized an expert seminar in Beijing to address these issues.The seminar focused on two common problems:"dual-person dual-lock"and"life-cycle information management".Experts thoroughly discussed the implementation of the"dual-person dual-lock"system and the management of life-cycle information,considering technical feasibility and specific content in the era of innovative technology.Consensus was reached among experts on the implementation of specific technologies and management modes to address expert consensus.

关 键 词：高致病性病原微生物 菌(毒)种 样本 双人双锁 全生命周期信息 管理 

分 类 号：Q338[生物学—遗传学]